Comparison of the long-term outcomes of kidney transplantation: USA versus Spain

被引:74
作者
Ojo, Akinlolu O. [1 ,2 ]
Maria Morales, Jose [3 ]
Gonzalez-Molina, Miguel [4 ]
Steffick, Diane E. [2 ]
Luan, Fu L. [1 ]
Merion, Robert M. [2 ,5 ]
Ojo, Tammy [1 ]
Moreso, Francesc [6 ]
Arias, Manuel [7 ]
Maria Campistol, Josep [8 ]
Hernandez, Domingo [9 ]
Seron, Daniel [10 ]
机构
[1] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
[2] Arbor Res Collaborat Hlth, Ann Arbor, MI USA
[3] Hosp 12 Octubre, Dept Nephrol, E-28041 Madrid, Spain
[4] Hosp Univ Carlos Haya, Dept Nephrol, Malaga, Spain
[5] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
[6] Hosp Univ Bellvitge, Dept Nephrol, Barcelona, Spain
[7] Hosp Univ Marques de Valdecilla, Dept Nephrol, Santander, Spain
[8] Hosp Clin Barcelona, Dept Nephrol & Kidney Transplantat, Barcelona, Spain
[9] Carlos Haya Univ Hosp, Div Nephrol, Malaga, Spain
[10] Hosp Univ Vall dhebron, Dept Nephrol, Barcelona, Spain
关键词
death with a functioning allograft; diabetes mellitus; end stage renal disease; graft survival; international comparison; UNITED-STATES; RENAL-TRANSPLANTATION; DIALYSIS OUTCOMES; PRACTICE PATTERNS; RECIPIENTS; MORTALITY; EUROPE; SURVIVAL; DISEASE; JAPAN;
D O I
10.1093/ndt/gfs287
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Background. The long-term outcomes of kidney transplantation are suboptimal because many patients lose their allografts or experience premature death. Cross-country comparisons of long-term outcomes of kidney transplantation may provide insight into factors contributing to premature graft failure and death. We evaluated the rates of late graft failure and death among US and Spanish kidney recipients. Methods. This is a cohort study of US (n = 9609) and Spanish (n = 3 8 0 8) patients who received a deceased donor kidney transplant in 1990, 1994, 1998 or 2002 and had a functioning allograft 1 year after transplantation with follow-up through September 2006. Ten-year overall and death-censored graft survival and 10-year overall recipient survival and death with graft function (DWGF) were estimated with multivariate Cox models. Results. Among recipients alive with graft function 1 year after transplant, the 10-year graft survival was 71.3% for Spanish and 53.4% for US recipients (P < 0.001). The 10-year, death-censored graft survival was 75.6 and 76.0% for Spanish and US recipients, respectively (P = 0.73). The 10-year recipient survival was 86.2% for Spanish and 67.4% for US recipients (P < 0.001). In recipients with diabetes as the cause of ESRD, the adjusted DWGF rates at 10 years were 23.9 and 53.8 per 1000 person-years for Spanish and US recipients, respectively (P < 0.001). Among recipients whose cause of ESRD was not diabetes mellitus, the adjusted 10-year DWGF rates were 11.0 and 25.4 per 1000 person-years for Spanish and US recipients, respectively. Conclusions. US kidney transplant recipients had more than twice the long-term hazard of DWGF compared with Spanish kidney transplant recipients and similar levels of death-censored graft function. Pre-transplant medical care, comorbidities, such as cardiovascular disease, and their management in each country's health system are possible explanations for the differences between the two countries.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 29 条
[1]
Barriers to cadaveric renal transplantation among blacks, women, and the poor [J].
Alexander, GC ;
Sehgal, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (13) :1148-1152
[2]
1997 Spanish Nephrology Association (Sociedad Espanola de Nefrologia) Report on Dialysis and Transplantation [J].
Amenábar, JJ ;
Garcia-López, F ;
Robles, NR ;
Saracho, R ;
Calero, M ;
Gentil, MA ;
Aladren, MJ ;
Martin-Martinez, E ;
Isles, B ;
Bestard, J ;
Marco, J ;
Lorenzo, V ;
de Francisco, ALM ;
Sierra, T ;
León, C ;
Rodrigo, A ;
Clèries, M ;
Vela, E ;
Robles, NR ;
Otero, F ;
Sánchez-Casajús, A ;
Rodríguez-Gironés, M ;
Solozábal, C ;
Magaz, A ;
García-Blasco, MJ ;
Zurriaga, O ;
Zamora, I ;
Vallo, A .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (12) :2841-2845
[3]
Amenábar JJ, 2002, NEFROLOGIA, V22, P310
[4]
[Anonymous], 2004, TABL H 4 ANN MORT RA
[5]
Rabbit antithymocyte globulin versus basiliximab in renal transplantation [J].
Brennan, Daniel C. ;
Daller, John A. ;
Lake, Kathleen D. ;
Cibrik, Diane ;
Del Castillo, Domingo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19) :1967-1977
[6]
RACIAL-DIFFERENCES IN THE SURVIVAL OF CADAVERIC RENAL-ALLOGRAFTS - OVERRIDING EFFECTS OF HLA MATCHING AND SOCIOECONOMIC-FACTORS [J].
BUTKUS, DE ;
MEYDRECH, EF ;
RAJU, SS .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (12) :840-845
[7]
Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review [J].
Butler, JA ;
Roderick, P ;
Mullee, M ;
Mason, JC ;
Peveler, RC .
TRANSPLANTATION, 2004, 77 (05) :769-776
[8]
CDC/NCHS, 2012, NAT VIT STAT S UNPUB
[9]
Transplant data: sources, collection and research considerations, 2004 [J].
Dickinson, DM ;
Dykstra, DM ;
Levine, GN ;
Li, SQ ;
Welch, JC ;
Webb, RL .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (04) :850-861
[10]
Medical care of kidney transplant recipients after the first posttransplant [J].
Djamali, Arjang ;
Samaniego, Millie ;
Muth, Brenda ;
Muehrer, Rebecca ;
Hofmann, R. Michael ;
Pirsch, John ;
Howard, Andrew ;
Mourad, Georges ;
Becker, Bryan N. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (04) :623-640